Gastrointestinal complications associated with the use of atropine in horses.
- Case Reports
- Journal Article
Summary
This study explored the effects of atropine on the gastrointestinal health of horses, finding that it could stop intestinal motility and potentially lead to abdominal pain, thus recommending against its use to alleviate intestinal spasms in horses.
Research Objective and Methodology
In this study, the researchers aimed to understand the effects of the drug Atropine sulfate on the gastrointestinal tract of horses. The dosage was given in two different concentrations (0.044 mg/kg and 0.176 mg/kg) to clinically normal ponies. The effects were carefully monitored, especially focusing on intestinal motility, which was evaluated by auscultating or listening to the sounds of the pony’s digestive system.
- Intestinal motility, in particular, is highlighted as a significant factor. This refers to the contraction of the muscle in the GI tract, which allows food and waste to move through for digestion and excretion, crucial for the health and well-being of the animal.
Findings
The studies showed that intestinal motility in the ponies ceased 30 minutes after administering the drug, but it slowly returned to normal within a span of 12 hours. However, symptoms of abdominal pain developed in 3 out of the 10 ponies tested.
- The study also observed that in three clinical cases where horses had gastrointestinal disorders, the previous treatment of atropine muddled the process of accurately diagnosing the issues, leading to a delay in surgical treatment in one of the cases.
Conclusion
Based on the findings, the study concluded that using atropine as a treatment for alleviating intestinal spasms in horses might not be a good option.
- This conclusion is drawn from the observations of abdominal pain in some ponies, the cessation of intestinal movements, and the complications it can cause in diagnosing other gastrointestinal disorders.
- The potential delay in necessary surgical treatments caused by the confusion in diagnosis due to prior atropine treatment further supports this conclusion.
Cite This Article
Publication
Researcher Affiliations
MeSH Terms
- Abdomen
- Animals
- Atropine / administration & dosage
- Atropine / adverse effects
- Colic / chemically induced
- Colic / veterinary
- Female
- Gastrointestinal Motility / drug effects
- Horse Diseases / chemically induced
- Horse Diseases / drug therapy
- Horses
- Intestinal Obstruction / chemically induced
- Intestinal Obstruction / veterinary
- Male
- Pain / drug therapy
- Pain / veterinary
Citations
This article has been cited 6 times.- Ekstrand C, Michanek P, Gehring R, Sundell A, Källse A, Hedeland M, Ström L. Plasma atropine concentrations associated with decreased intestinal motility in horses. Front Vet Sci 2022;9:951300.
- Ström L, Dalin F, Domberg M, Stenlund C, Bondesson U, Hedeland M, Toutain PL, Ekstrand C. Topical ophthalmic atropine in horses, pharmacokinetics and effect on intestinal motility. BMC Vet Res 2021 Apr 7;17(1):149.
- Dyson DH, Pascoe PJ, McDonell WN. Effects of intravenously administered glycopyrrolate in anesthetized horses. Can Vet J 1999 Jan;40(1):29-32.
- Singh S, Young SS, McDonell WN, O'Grady M. Modification of cardiopulmonary and intestinal motility effects of xylazine with glycopyrrolate in horses. Can J Vet Res 1997 Apr;61(2):99-107.
- Boatwright CE, Fubini SL, Grohn YT, Goossens L. A comparison of N-butylscopolammonium bromide and butorphanol tartrate for analgesia using a balloon model of abdominal pain in ponies. Can J Vet Res 1996 Jan;60(1):65-8.
- Varner KM, Curtiss AL, Hogan PM, Love K, Dodam JR. Retrospective evaluation of the impact of atropine administration on incidence of post-operative colic in healthy, isoflurane-anaesthetised horses. Equine Vet J 2025 Jul;57(4):924-930.